Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
-20C, 1 month (sealed storage, away from moisture)
The risk of significant microbial growth is too high, even with the preservative
Rev Med Interne
established that alpha-MSH C-terminal fragments, including the KPV sequence, reduce contact hypersensitivity and produce meaningful anti-inflammatory effects in dermal models.6 Conditions Under Investigation In preclinical models, KPV has shown relevance to: Eczema and atopic dermatitis conditions driven by dysregulated Th2 immune responses and skin barrier failure Psoriasis characterized by keratinocyte hyperproliferation and NF-B overactivation Contact hypersensitivity where KPV's ability to modulate immune cell activation in dermal tissue has been demonstrated directly Wound healing where suppression of excess inflammation supports tissue repair rather than hindering it No large-scale human trials exist for dermatological applications yet
Second, vet your sources relentlessly
We don't know
US$ 23.85
US$ 22.85
US$ 21.93
US$ 22.39
US$ 26.68
